Analytica Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 10 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 30.57%
- Ebitda 50.44%
- Net Worth -0.27%
- Total Assets -0.15%
About Analytica Life Sciences
Analytica Life Sciences Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 February 2012 and has a history of 13 years. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nadimpally Subramanyaraju and Sreenivasa Suragam serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233TG2012PTC079124
- Company No.
079124
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2012
- Date of AGM
12 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Analytica Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nadimpally Subramanyaraju  | Director | 13-Feb-2012 | Current |
| Sreenivasa Suragam | Director | 13-Feb-2012 | Current |
Financial Performance of Analytica Life Sciences.
Analytica Life Sciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 30.57% increase in profit. The company's net worth dipped by a decrease of 0.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Analytica Life Sciences?
In 2019, Analytica Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mallika Hortigreen LlpNadimpally Subramanyaraju is a mutual person
- Pudami Industries Private Limited
Nadimpally Subramanyaraju is a mutual person
- Vrudhi Industries Private Limited
Nadimpally Subramanyaraju is a mutual person
- Srigirinivasa Developers Llp
Sreenivasa Suragam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Analytica Life Sciences?
Unlock and access historical data on people associated with Analytica Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Analytica Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Analytica Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.